Departments of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Addict Biol. 2013 Jan;18(1):181-92. doi: 10.1111/j.1369-1600.2011.00430.x. Epub 2012 Jan 20.
Hypothalamic-pituitary-adrenal (HPA) axis responses following naloxone administration have been assumed to provide a measure of opioid receptor activity. Employing positron emission tomography (PET) using the mu opioid receptor (MOR) selective ligand [(11)C] carfentanil (CFN), we demonstrated that cortisol responses to naloxone administration were negatively correlated with MOR availability. In this study, we examined whether naloxone-induced cortisol and adrenocorticotropin (ACTH) responses in 15 healthy control and 20 recently detoxified alcohol-dependent subjects correlated with delta opioid receptor (DOR) availability in 15 brain regions using the DOR-selective ligand [(11)C] methyl-naltrindole (MeNTL) and PET imaging. The day after the scan, cortisol responses to cumulative doses of naloxone were determined. Peak cortisol and ACTH levels and area under the cortisol and ACTH curve did not differ by group. There were negative relationships between cortisol area under curve to naloxone and [(11)C] MeNTL-binding potential (BP(ND)) in the ventral striatum, anterior cingulate, fusiform cortices, temporal cortex, putamen and a trend in the hypothalamus of healthy control subjects. However, in alcohol-dependent subjects, cortisol responses did not correlate with [(11)C]MeNTL BP(ND) in any brain region. Plasma ACTH levels did not correlate with [(11)C]MeNTL BP(ND) in either group. The study demonstrates that naloxone provides information about individual differences in DOR availability in several mesolimbic structures. The data also show that the HPA axis is intimately connected with mesolimbic stress pathways through opioidergic neurotransmission in healthy subjects but this relationship is disrupted during early abstinence in alcohol-dependent subjects.
在下丘脑-垂体-肾上腺 (HPA) 轴对纳洛酮给药的反应被认为是提供阿片受体活性的一种衡量标准。我们使用正电子发射断层扫描 (PET) 结合μ阿片受体 (MOR) 选择性配体 [(11)C] 卡芬太尼 (CFN),证明了纳洛酮给药后皮质醇反应与 MOR 可用性呈负相关。在这项研究中,我们检查了 15 名健康对照者和 20 名最近戒酒的酒精依赖者在接受纳洛酮诱导后皮质醇和促肾上腺皮质激素 (ACTH) 的反应是否与 15 个脑区中 δ 阿片受体 (DOR) 的可用性相关,方法是使用 DOR 选择性配体 [(11)C] 甲基-纳曲吲哚 (MeNTL) 和 PET 成像。扫描后的第二天,确定了皮质醇对纳洛酮累积剂量的反应。两组的皮质醇峰值和 ACTH 水平以及皮质醇和 ACTH 曲线下面积均无差异。健康对照组中,皮质醇曲线下面积与腹侧纹状体、前扣带回、梭状回、颞叶皮质、壳核和下丘脑的 [(11)C]MeNTL 结合潜能 (BP(ND)) 呈负相关。然而,在酒精依赖者中,皮质醇反应与任何脑区的 [(11)C]MeNTL BP(ND) 均不相关。两组的血浆 ACTH 水平均与 [(11)C]MeNTL BP(ND) 不相关。该研究表明,纳洛酮提供了关于几个中脑边缘结构中 DOR 可用性个体差异的信息。该数据还表明,在健康受试者中,HPA 轴与中脑边缘应激途径通过阿片能神经传递紧密相连,但在酒精依赖者的早期戒断期间,这种关系被破坏。